Evidence map›Paper›PMID 42190814›Full record

ArticleThe Journal of biological chemistry2026

SARS-CoV-2 5'-UTR stem-loops activate the antiviral protein oligoadenylate synthetase 1 (OAS1).

Alejandro Oviedo, Camden R Bair, Alexander P Vasilakopoulos, Kierra Regis, David Vanlnsberghe, Anice C Lowen, Graeme L Conn

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Alejandro OviedoDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA; Graduate Program in Biochemistry, Cell and Developmental Biology, Emory University, Atlanta, Georgia, USA.
Camden R BairDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Alexander P VasilakopoulosDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
Kierra RegisDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA.
David VanlnsbergheDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Anice C LowenDepartment of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA.
Graeme L ConnDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia, USA. Electronic address: gconn@emory.edu.

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
dsRNA regulation of the cytosolic innate immune systemR01AI144067 · NIAID · EMORY UNIVERSITY · PI Graeme L Conn · 2019 to 2026
$3.4M
Illumina NovaSeq 6000 High Throughput DNA Sequencer for Emory UniversityS10OD026799 · OD · EMORY UNIVERSITY · PI BOSINGER, STEVEN EDWARD · 2019 to 2019
$985k
NIAID NIH HHS R01 AI144067NIH HHS P51 OD011132NIH HHS S10 OD026799
6 · The paper itself

Abstract

The innate immune system relies on pathogen recognition receptors, such as the 2',5'-oligoadenylate synthetase (OAS) proteins, to detect pathogen-associated molecular patterns like viral double-stranded (ds)RNA. A specific splicing variant of OAS1 (OAS1-p46) has been implicated in initiating an immune response that leads to decreased disease severity during SARS-CoV-2 infection. OAS1-p46 has a C-terminal lipid modification motif that allows for anchoring of the protein to intracellular membranes and thus potential colocalization with immunogenic viral RNA regions such as the SARS-CoV-2 5'-untranslated region (5'-UTR). Here, we show that OAS proteins can detect the 5'-structured elements (5'-SE)-comprising the 5'-UTR and three additional stem-loop structures-and activate the cellular RNase L pathway. Through systematic 3'-end truncations of the 5'-SE, we show that the smallest 5'-SE fragment capable of potently activating OAS1 is the conserved and highly structured SL1-4b region, containing the first four stem-loop structures and their intervening linking sequences (SL1-4), as well as an unstructured region ("SL4b") to the 3'-side of SL4. Analyses of OAS1 activation and RNA secondary structure probing using selective 2'-hydroxyl acylation analyzed by primer extension and mutational profiling (SHAPE-MaP) of additional SL1-4b RNA variants suggests a model in which SL4 acts as the primary OAS1 interaction site, while the unstructured SL4b region and two other stem-loops (SL1 and SL3) are necessary for optimal presentation of this region for OAS1 activation. Our findings reveal a structurally complex viral RNA region that potently activates OAS1, underscoring the potential complexity of RNAs that can strongly activate this innate immune sensor.

Indexed as

2',5'-Oligoadenylate Synthetase5' Untranslated RegionsRNA, ViralSARS-CoV-2EndoribonucleasesHumansNucleic Acid Conformation2-5A-dependent ribonuclease2',5'-Oligoadenylate Synthetase5' Untranslated RegionsEndoribonucleasesOAS1 protein, humanRNA, Viralantiviraldouble-stranded RNA (dsRNA)innate immunityoligoadenylate synthetaseRNA structure

Identifiers

PMID42190814
PMCPMC13315676

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.